Christopher Zurenko

Alnylam Pharmaceuticals (United States)

Papers

1

Total Citations

200

H-Index

1

About

Christopher Zurenko is a pioneer in the high-throughput design of nanomaterials for intracellular delivery, with his work bridging combinatorial chemistry and nanomedicine. His most influential contribution, the 2011 study on combinatorial synthesis of chemically diverse core-shell nanoparticles, introduced a modular, assembly-line approach that enabled the systematic evaluation of 1,536 distinct nanoparticle variants. By varying cationic cores and shell compositions, Zurenko uncovered critical trends in complexation, cellular internalization, and cargo delivery—insights that would have been impossible to glean from isolated experiments. This landmark paper, which has garnered over 200 citations, established a paradigm for rationally engineering nanoparticles with tailored biological performance. Zurenko’s research has profound implications for gene therapy and drug delivery, offering a blueprint for accelerating the discovery of effective nanocarriers. His work exemplifies how high-throughput screening can transform nanomedicine, moving from trial-and-error to data-driven design. For students and researchers, Zurenko’s contributions demonstrate the power of combinatorial thinking in solving complex biological delivery challenges, making him a key figure in the evolution of smart, responsive nanomaterials.

Research Focus

Key Achievements

1
H-Index
1
Papers
200
Total Citations
200
Avg Citations/Paper
🏆 Most Cited Paper
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery
200 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Alnylam Pharmaceuticals (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago